Atacand and Affect lability - a phase IV clinical study of FDA data

Summary:

Affect lability is reported as a side effect among people who take Atacand (candesartan cilexetil), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prednisone, and have Diabetes.

The phase IV clinical study analyzes which people have Affect lability when taking Atacand. It is created by eHealthMe based on reports of 21,732 people who have side effects when taking Atacand from the FDA, and is updated regularly.

What is Atacand?

Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 22,473 Atacand users. Check the latest studies of Atacand.

What is Affect lability?

Affect lability (emotional incontinence) is found to be associated with 670 drugs and 829 conditions by eHealthMe. Check the latest studies of Affect lability.

On Aug, 01, 2026

21,732 people reported to have side effects when taking Atacand.
Among them, 66 people (0.3%) have Affect lability.

Among these 66 people:

How long have people been on Atacand when they have Affect lability? *

What is the gender of people who have Affect lability when taking Atacand? *

female: 94.83 %
male: 5.17 %

What is the age of people who have Affect lability when taking Atacand? *

What are other drugs people take besides Atacand? *

Prednisone: 62 people, 93.94%
Synthroid: 61 people, 92.42%
Acetaminophen: 60 people, 90.91%
Avapro: 60 people, 90.91%
Lisinopril: 60 people, 90.91%
Prochlorperazine: 59 people, 89.39%
Diphenhydramine Hydrochloride: 59 people, 89.39%
Gliclazide: 59 people, 89.39%
Januvia: 59 people, 89.39%
Morphine Sulfate: 59 people, 89.39%

What are other side effects people have besides Affect lability? *

Fatigue (feeling of tiredness): 63 people, 95.45%
Chest Pain: 63 people, 95.45%
Stress And Anxiety: 63 people, 95.45%
Confusional State: 62 people, 93.94%
Nausea (feeling of having an urge to vomit): 62 people, 93.94%
Headache (pain in head): 62 people, 93.94%
Fever: 61 people, 92.42%
Urinary Tract Infection: 60 people, 90.91%
Hemiplegia (paralysis of one side of the body): 59 people, 89.39%
Hemiparesis (weakness on one side of the body): 59 people, 89.39%

What are the existing conditions these people have? *

Nausea And Vomiting: 57 people, 86.36%
Diabetes: 57 people, 86.36%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 55 people, 83.33%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 52 people, 78.79%
Psoriasis (immune-mediated disease that affects the skin): 51 people, 77.27%
Microalbuminuria (albumin into the urine): 50 people, 75.76%
Type 2 Diabetes: 1 person, 1.52%
High Blood Cholesterol: 1 person, 1.52%
Depression: 1 person, 1.52%
Bipolar Disorder (mood disorder): 1 person, 1.52%

* Approximation only. Some reports may have incomplete information.

Do you take Atacand and have Affect lability?

- Check whether Affect lability is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atacand:

Atacand (22,473 reports)

Affect lability treatments and more:

Affect lability (13,491 reports)

Browse all side effects of Atacand:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Affect lability:

Affect lability (670 drugs)

Browse all the conditions that are associated with Affect lability:

Affect lability (829 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on candesartan cilexetil (the active ingredients of Atacand) and Atacand (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.